APEX-STROKE Adaptive Platform Trial for Stroke
A phase 3 trial registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 20000 participants.
Also called NCT07784569
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose treatment
- Phase
- Phase 3
- Enrolled
- 20,000 participants
- Sponsor
- Registry
-
NCT07784569
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07784569. Randomized; single masking; primary purpose treatment. Start 2026-09-01 (anticipated); primary completion 2029-06-30 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- APEX-STROKE Adaptive Platform Trial for Stroke
- Condition
- Stroke
- Intervention (Drug)
- Early Angong Niuhuang Pill Treatment
- Intervention (Drug)
- Yiqi Huayu Jiedu Mixture
- Intervention (Procedure)
- Surgical bundle
- Lead sponsor
- Fudan University
- Collaborator
- Huashan Hospital
- Collaborator
- Chinese PLA General Hospital
- Collaborator
- Beijing University of Chinese Medicine
- Collaborator
- Hubei College of Traditional Chinese Medicine
- Collaborator
- Guangdong Provincial Hospital of Traditional Chinese Medicine
Record details
- Record id
cardio:ct-nct07784569- Content hash
4aaf53f6bb70e29c85c05672c4dd1dd2593a61e491708f0dcc31ed463752d20c